Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
Pfizer
Alliance for Clinical Trials in Oncology
Case Comprehensive Cancer Center
Merus B.V.
M.D. Anderson Cancer Center
Syndax Pharmaceuticals
M.D. Anderson Cancer Center
Fudan University
UNICANCER
The First Affiliated Hospital with Nanjing Medical University
Incyte Corporation
Region Skane
DEKA Biosciences
Sixth Affiliated Hospital, Sun Yat-sen University
Assistance Publique - Hôpitaux de Paris
Taproot Health
Shengjing Hospital
Fudan University
Anhui Provincial Hospital
Persephone Biosciences
Celldex Therapeutics
Oslo University Hospital
Alliance for Clinical Trials in Oncology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Fudan University
Fudan University
Zhejiang University
Sun Yat-sen University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Zhejiang University
Amgen
Fudan University
Fudan University
Second Affiliated Hospital, School of Medicine, Zhejiang University
State Scientific Centre of Coloproctology, Russian Federation
Dana-Farber Cancer Institute
Fudan University
Chinese PLA General Hospital
UNICANCER
Federation Francophone de Cancerologie Digestive
Fudan University
University of Leicester
Sinocelltech Ltd.
University of Wisconsin, Madison
Peking University
UNICANCER
Hoffmann-La Roche
Hoffmann-La Roche